The FDA has cleared its first completely at-home sexual health test for women, available over-the-counter to screen for ...
Relmada Therapeutics’ attempts to see whether a magic mushroom extract could be used to treat obesity and metabolic diseases ...
BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. | BioNTech has shown ...
BioAtla is laying off 30% of staff as the biotech searches for partners for some of its conditionally active biologic (CAB) ...
Novo inks $1B biobucks Lexicon obesity deal after seeing preclinical prospect shine with semaglutide
Lexicon Pharmaceuticals’ pursuit of the last word in obesity candidates has attracted Novo Nordisk. | Lexicon Pharmaceuticals ...
Since the first days of the new Trump administration, the White House has handed down orders to ban work focused on diversity ...
Having stripped back its workforce, antibiotics biotech Spero Therapeutics continues to strip away its remaining pipeline. | ...
CRISPR Therapeutics’ Julianne Bruno is hitting the exit in favor of external opportunities, marking the latest shakeup to the ...
Ian Lipkin, M.D., and his team at Columbia University submitted a paper for publication that suggests certain approved drugs could possibly be repurposed for a severe fatigue condition that currently ...
The federal government is cutting 3,500 full-time FDA employees and 1,200 NIH workers as part of an overarching move designed ...
Lyndra Therapeutics, which spun out of Moderna co-founder Robert Langer’s lab at the Massachusetts Institute of Technology in ...
Schwetz’s leave will be effective as of 5 p.m. today, Stat reported yesterday. The news broke the same day that the Senate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback